Lilly says Foundayo pill eased sleep apnea in trial
Eli Lilly (LLY) said on Monday November 9 that its obesity pill Foundayo reduced the severity of sleep apnea in a late-stage trial. Lilly plans to file for U.S. approval by the end of the year. Patients not using a breathing machine saw their breathing interruptions fall 43.8%, against 6.3% on placebo. Claude Wallet and David J. Taylor hold LLY long.
Sources
Lilly says Foundayo eases sleep apnea in trial
The whole story · updated
CN
CNBC
·
Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval